Hilarious. Enos is not 2 to 3 times more valuable than any multi port. In the end, in
Total volume four a company if they had a nose and a high quality multi port the multiport volume overall will do 60+ percent of the cases easily. Any valuation will reflect that …
A good multi port can do ANY procedure. SP, including Enos CANNOT … even with the flexible arms. Add the fact that ENOS only has two arms and it further limits it’s capabilities.
I suggest talking to real surgeons before making these ridiculous claims. Your claims either come from blindly supporting this stock or complete lack of understanding of the needs of triangulation in more complex procedures.
But hey, 2 or 3 times ($6-9B) The $3 Billion CMR valuation seems reasonable LOL.
BelizeMe
News 
Market Data 
Discover 
